Olimel N9

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Olimel N9, is a mixture of essential and non‑essential amino acids presented as a powder for oral solution use. It supports metabolic functions and protein synthesis in patients requiring nutritional supplementation.

GNH USA supplies Olimel N9 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Olimel N9 provides amino acid supplementation for conditions where protein metabolism is compromised. - Premature infants: supports growth and development when endogenous amino acid production is insufficient. - Post‑surgical patients: aids recovery by supplying essential building blocks for tissue repair. - Chronic kidney disease patients on dialysis: helps maintain nitrogen balance and muscle mass. - Severe malnutrition: contributes to re‑establishment of normal protein turnover. - Metabolic disorders involving amino‑acid loss: assists in correcting deficiencies.

Adverse reactions to amino‑acid mixtures are generally mild and related to the gastrointestinal tract or hypersensitivity.

Common Side Effects: - Nausea: occasional feeling of queasiness. - Vomiting: intermittent episodes, usually mild. - Diarrhea: loose stools that resolve with continued use. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in mouthfeel. - Injection site irritation: mild redness if administered via feeding tube.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Hyperammonemia: elevated blood ammonia levels in patients with severe liver dysfunction. - Metabolic acidosis: rare disturbance of acid‑base balance. - Severe electrolyte imbalance: uncommon but may occur with large-volume administration. - Hypersensitivity rash: widespread skin eruption. - Pulmonary edema: extremely rare fluid accumulation in lungs.

When using Olimel N9, consider patient‑specific factors and follow standard handling practices. - Renal impairment: adjust volume based on individual fluid tolerance. - Hepatic dysfunction: monitor ammonia levels during therapy. - Electrolyte monitoring: check serum electrolytes regularly in high‑risk patients. - Feeding tube compatibility: verify that the formulation does not clog the tube. - Pediatric use: dose must be calculated by a qualified clinician. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Amino‑acid mixtures can interact with certain medications and clinical conditions.

Major Interactions (Avoid): - Phenylalanine‑containing formulations: may exacerbate phenylketonuria. - High‑protein enteral formulas: risk of excessive nitrogen load.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., valproate): may alter plasma amino‑acid levels. - Diuretics: increase risk of electrolyte disturbances when combined with large‑volume amino‑acid solutions. - Insulin therapy: may require adjustment of carbohydrate content in the nutrition regimen. - Renal replacement therapies: affect clearance of administered amino acids. - Thyroid hormone replacement: monitor thyroid function tests as amino‑acid load can influence hormone binding.